GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » Gross Profit

TOWA Pharmaceutical Co (TSE:4553) Gross Profit : 円81,383 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co Gross Profit?

TOWA Pharmaceutical Co's gross profit for the three months ended in Dec. 2023 was 円22,168 Mil. TOWA Pharmaceutical Co's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was 円81,383 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. TOWA Pharmaceutical Co's gross profit for the three months ended in Dec. 2023 was 円22,168 Mil. TOWA Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円60,929 Mil. Therefore, TOWA Pharmaceutical Co's Gross Margin % for the quarter that ended in Dec. 2023 was 36.38%.

TOWA Pharmaceutical Co had a gross margin of 36.38% for the quarter that ended in Dec. 2023 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of TOWA Pharmaceutical Co was 51.75%. The lowest was 34.81%. And the median was 45.92%.

Warning Sign:

TOWA Pharmaceutical Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -5.8%.


TOWA Pharmaceutical Co Gross Profit Historical Data

The historical data trend for TOWA Pharmaceutical Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Gross Profit Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50,646.00 65,451.00 70,185.00 72,713.00 81,383.00

TOWA Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21,662.00 20,008.00 18,232.00 22,168.00 20,975.00

Competitive Comparison of TOWA Pharmaceutical Co's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Gross Profit falls into.



TOWA Pharmaceutical Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

TOWA Pharmaceutical Co's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=227934 - 146551
=81,383

TOWA Pharmaceutical Co's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=60929 - 38761
=22,168

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円81,383 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

TOWA Pharmaceutical Co's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=22,168 / 60929
=36.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


TOWA Pharmaceutical Co  (TSE:4553) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

TOWA Pharmaceutical Co had a gross margin of 36.38% for the quarter that ended in Dec. 2023 => Competition eroding margins


TOWA Pharmaceutical Co Gross Profit Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co (TSE:4553) Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TSE:4553) Headlines

No Headlines